BANCA MEDIOLANUM S.P.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.79 EUR | +2.57% |
|
+5.99% | +26.44% |
| May. 09 | Transcript : Banca Mediolanum S.p.A., Q1 2024 Earnings Call, May 09, 2024 | |
| May. 09 | Mediolanum increases profit; EUR66 million buyback on track | AN |
Summary
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- With a P/E ratio at 10.35 for the current year and 9.38 for next year, earnings multiples are highly attractive compared with competitors.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The company is one of the best yield companies with high dividend expectations.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- The group usually releases upbeat results with huge surprise rates.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Banks
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +26.44% | 8.61B | A- | ||
| +16.85% | 571B | C+ | ||
| +14.20% | 301B | C+ | ||
| +18.59% | 252B | C+ | ||
| +25.74% | 216B | C | ||
| +21.29% | 183B | B- | ||
| +25.50% | 170B | B- | ||
| +9.52% | 162B | C+ | ||
| +5.28% | 146B | B- | ||
| -15.88% | 131B | B- |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- BMED Stock
- Ratings Banca Mediolanum S.p.A.